• Family of patient who died after orthopedic surgery wins $35M verdict against hospital
  • Orthopedic surgeon wins $20M verdict against Johnson & Johnson
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon's video hits 1 million views on TikTok
  • Spine surgeon killed in Oklahoma hospital shooting
  • Spine surgeon owes $17M to paralyzed patient
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • 23 spine device companies to watch in 2022
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon salary vs. average household income in each state
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon convicted of battery at hospital
  • Billionaire spine surgeon buys $23.9M mansion
  • UArizona neurosurgery chair dies after motorcycle collision
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • The spine tech surgeons say will explode in the next 5 years
  • Could Medtronic's spine business be the next medtech spinoff?
  • Ex-NFL player gets 5 years in prison for $2.9M healthcare fraud scheme
  • 41 'rising stars' in orthopedics
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon fined for operating on wrong knee
  • Lawsuits build against Aetna's spine surgery coverage
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Former spine surgeon owes $13M to 2 women over unnecessary procedures
  • Walmart's latest partnership pushes retailer into spine care
  • Texas spine surgeon's $11M verdict being appealed
  • 10 power players in orthopedics
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon allegedly exaggerated patient visits to defraud insurers
  • Top orthopedic hospital in every state: US News
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • How Medtronic is strengthening its spine business
  • $85M settlement reached in spinal cord stimulation lawsuits
  • Medtronic's next-gen predictive spine surgery model cleared
  • ZimVie's pediatric scoliosis device gets coverage by Anthem BCBS
  • Spinal fusion alternative device reaches FDA milestone
  • Texas spine center enrolls 10th patient in multilevel disc replacement trial

    Texas spine center enrolls 10th patient in multilevel disc replacement trial

    Paige Haeffele -  

    Texas Spine Care Center in San Antonio has enrolled its 10th patient in a trial comparing the safety and effectiveness of Centinel Spine's disc replacement products to a similar FDA-approved product. 

    The multicenter, prospective, randomized controlled trial compares Centinel's Prodisc C SK and Prodisc C Vivo to Zimmer Biomet's Mobi-C cervical disc in the treatment of two-level symptomatic cervical disc disease, Texas Spine Care and Centinel said in a May 24 news release. The Prodisc models being tested are built on the Prodisc technology platform, the world's most widely used total disc replacement system. 

    Prodisc technology has been used in over 125,000 device implants worldwide in the last 30 years, and the trial is testing the devices to earn FDA approval for multilevel use in the U.S.

    The trial's patients will be evaluated before surgery and two weeks, six weeks, three months, six months, one year and two years after surgery. After the two-year evaluation, the patients will potentially be asked to return for annual evaluations for seven years.

    The goal is to enroll approximately 20 patients at Texas Spine Care Center out of 390 study participants overall.

    More information about the trial can be found here.

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Learning Opportunities

    Featured Webinars

    Featured Podcast

    Featured Whitepapers